Bone marrow edema in osteoarthritis of the knee joint
Open Access
- 24 January 2024
- journal article
- review article
- Published by Publishing House OKI in Patient-Oriented Medicine and Pharmacy
- Vol. 1 (4) , 29-42
Abstract
The term "bone marrow edema" (BME) in MRI examination of the knee joint is used to describe areas of decreased signal intensity on T1-weighted images or increased signal intensity on T2-weighted images in the subchondral bone. BME is classified into ischemic (osteonecrosis), mechanical (trauma), and reactive (arthritis) types. In this review, the causes and differences in BME with spontaneous and secondary osteonecrosis and other characteristics of BME transitioning to a syndrome are considered. BME with injuries and bruises is usually reversible and passes after approximately 2–4 months, if accompanied by a cortical fracture, after 6–12 months. A fatigue fracture develops as a result of repeated overloading of normal bone structures, whereas fractures in zones of subchondral bone insufficiency spontaneously occur in pathologically changed bone tissues (for example, osteoporotic bones) without any trauma or overloading. Histological examination of the damaged subchondral bone in ischemic and mechanical BME revealed hemorrhages, microdestruction of bone trabeculae and vascular anomalies, and almost complete absence of direct edema in MRI-positive zones due to increased extracellular fluid content, which can be partially explained by methodological difficulties in detecting increased extracellular fluid by histopathological methods. Prostacyclin and bisphosphonate have been proposed as conservative therapies for ischemic and mechanical BME.In osteoarthritis (OA) of the knee joints, BME is considered a marker of rapid progression. Data on the influence of obesity, therapeutic exercise and diet, and the use of a cane on BME are presented. Analysis of the effectiveness of conservative therapy revealed a weakly positive response to bisphosphonates. Inhibitors of nerve growth factor (NGF) — monoclonal antibodies to nerve growth factor (like tanezumab and fulranumab) — reduced the severity of pain but led to an increase in the frequency of osteonecrosis and endoprosthesis. Two studies have shown a decrease in the intensity of BME with oral chondroitin sulfate. The attention of orthopedists is focused on subchondroplasty using calcium phosphates. Subchondral filling, which strengthens the bone and replaces the lost barrier function of cartilage, has a symptomatic effect and effectively counteracts the development of BME, although the long-term results need to be studied.Keywords
This publication has 62 references indexed in Scilit:
- Subchondral bone in osteoarthritis: insight into risk factors and microstructural changesArthritis Research & Therapy, 2013
- Changes in bone marrow lesions in response to weight-loss in obese knee osteoarthritis patients: a prospective cohort studyBMC Musculoskeletal Disorders, 2013
- Pentosan polysulfate increases affinity between ADAMTS-5 and TIMP-3 through formation of an electrostatically driven trimolecular complexBiochemical Journal, 2012
- Inhibitory Effects of Pentosan Polysulfate Sodium on MAP-Kinase Pathway and NF-κB Nuclear Translocation in Canine Chondrocytes In VitroJournal of Veterinary Medical Science, 2012
- Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRIAnnals of the Rheumatic Diseases, 2011
- Subchondral Cystlike Lesions Develop Longitudinally in Areas of Bone Marrow Edema–like Lesions in Patients with or at Risk for Knee Osteoarthritis: Detection with MR Imaging—The MOST StudyRadiology, 2010
- Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritisAnnals of the Rheumatic Diseases, 2009
- Rationale for prostaglandin I2in bone marrow oedema – from theory to applicationArthritis Research & Therapy, 2008
- Bone marrow edema in the knee in osteoarthrosis and association with total knee arthroplasty within a three-year follow-upSkeletal Radiology, 2008
- Bone marrow edema-like lesions change in volume in the majority of patients with osteoarthritis; associations with clinical featuresEuropean Radiology, 2007